Ranked #1
Facing NASH Therapeutic Skepticism with 89bio's Rohan Palekar
Facing NASH Therapeutic Skepticism with 89bio's Rohan Palekar
The non-alcoholic steatohepatitis (NASH) therapeutics market has proven to be an 11/10 on the difficulty scale. Despite ... Read more
14 Aug 2023
•
52mins
Ranked #2
Biotech Cash Management with Allan Shaw
Biotech Cash Management with Allan Shaw
It’s been said that clinical trials are where emerging biotechs go to die. If the science doesn't kill quickly, poor cas... Read more
7 Aug 2023
•
47mins
Similar Podcasts
Ranked #3
Establishing Research With Horizon Therapeutics' Robert Stoffel, Ph.D.
Establishing Research With Horizon Therapeutics' Robert Stoffel, Ph.D.
While Horizon Therapeutics has made plenty of waves in the biotech news cycle of late. While perhaps not as flashy as a ... Read more
31 Jul 2023
•
47mins
Ranked #4
Surviving The Microbiome Market with MaaT Pharma's Hervé Affagard
Surviving The Microbiome Market with MaaT Pharma's Hervé Affagard
The microbiome therapeutics market has been taking a beating, with several clinical-stage companies failing or flailing ... Read more
24 Jul 2023
•
48mins
Ranked #5
COO Liftoff With Rocket Pharmaceuticals' Kinnari Patel, PharmD
COO Liftoff With Rocket Pharmaceuticals' Kinnari Patel, PharmD
Chief Operating Officer is arguably the toughest job in the emerging biopharma C-suite. HR, CMC, regulatory affairs, leg... Read more
17 Jul 2023
•
46mins
Ranked #6
ML-Enabled Drug Discovery With LabGenius' James Field, Ph.D.
ML-Enabled Drug Discovery With LabGenius' James Field, Ph.D.
Will machine learning revolutionize biopharma drug discovery? Has it already? This week on the Business of Biotech, we e... Read more
10 Jul 2023
•
46mins
Ranked #7
Biopharma Comebacks With Vincerx's Ahmed Hamdy, MD
Biopharma Comebacks With Vincerx's Ahmed Hamdy, MD
Ahmed Hamdy, MD didn’t ask to be the subject of Nathan Vardi's new book For Blood and Money: Billionaires, Biotech, and ... Read more
3 Jul 2023
•
47mins
Ranked #8
Origins Of A Biopharma VC Deal With Bernat Olle, Ph.D. and Parag Shah
Origins Of A Biopharma VC Deal With Bernat Olle, Ph.D. and Parag Shah
Last October, we dropped an episode dissecting the relationship between Ray Therapeutics and one of its lead funders, 4B... Read more
26 Jun 2023
•
1hr 14mins
Ranked #9
Population-Level Health Impact With Vaxxinity's John Krayacich
Population-Level Health Impact With Vaxxinity's John Krayacich
Vaxxinity’s John Krayacich likes taking big swings at big indications. He’s played key roles on the teams that launched ... Read more
19 Jun 2023
•
48mins
Ranked #10
The Face Of African Biotech with Adrienne Leussa, Ph.D.
The Face Of African Biotech with Adrienne Leussa, Ph.D.
Dr. Adrienne Leussa is one of my favorite follows. If the booming biotech scene on an incredibly diverse continent of 1.... Read more
12 Jun 2023
•
1hr 4mins